You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 078899

✉ Email this page to a colleague

« Back to Dashboard

NDA 078899 describes BROMOCRIPTINE MESYLATE, which is a drug marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Aurobindo Pharma Usa, Padagis Us, and Sandoz, and is included in six NDAs. It is available from five suppliers. Additional details are available on the BROMOCRIPTINE MESYLATE profile page.

The generic ingredient in BROMOCRIPTINE MESYLATE is bromocriptine mesylate. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.

Summary for 078899

Tradename:	BROMOCRIPTINE MESYLATE
Applicant:	Zydus Pharms Usa Inc
Ingredient:	bromocriptine mesylate
Patents:	0

Pharmacology for NDA: 078899

Medical Subject Heading (MeSH) Categories for 078899

Antiparkinson Agents
Dopamine Agonists
Hormone Antagonists

Suppliers and Packaging for NDA: 078899

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
BROMOCRIPTINE MESYLATE	bromocriptine mesylate	CAPSULE;ORAL	078899	ANDA	Zydus Lifesciences Limited	65841-654	65841-654-01	100 CAPSULE in 1 BOTTLE (65841-654-01)
BROMOCRIPTINE MESYLATE	bromocriptine mesylate	CAPSULE;ORAL	078899	ANDA	Zydus Lifesciences Limited	65841-654	65841-654-06	30 CAPSULE in 1 BOTTLE (65841-654-06)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 5MG BASE
Approval Date:	Jul 30, 2008	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.